BioAge Labs, Inc. cotiza a 5.94 USD y tiene una capitalización bursátil de $273M. En los últimos 12 meses ha facturado $10M con un margen de flujo de caja libre del -915.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate i…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.58 | $-0.52 | $-0.72 |
| Estimado | $-0.62 | $-0.62 | $-0.63 | $-0.67 |
| Sorpresa | — | +6.5% | +17.5% | -7.5% |
| Métrica | BIOA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -1031.5% | -38.6% | -992.8% |
| Net Margin | -896.1% | -33.6% | -862.5% |
| FCF Margin | -915.5% | -13.9% | -901.6% |
| ROE | -29.6% | -40.4% | +10.8% |
| ROA | -27.3% | -32.0% | +4.7% |
| Current Ratio | 14.24 | 2.84 | +11.40 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |